Yeah hasn’t been favoured more so because they just didn’t have enough research not that there wasn’t good studies out there, it just takes more and more evidence before making a global or large scale approval on anything really.
The scaling up of the sales is something the director talked about and wants to do. Cannabis products have been selling for years just tiny amounts of it and a very special populations only. So no large scale selling of it yet. Could change and if it does it’ll be huge. My market cap comment was specific to this company, hitting the same prices years ago may very well happen, but there’s a lot more shares on issue and takes larger numbers to now push the SP that high.
CPH Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
